| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 9, 2007
Accepted on April 9, 2008
From the Department of Physiology (Y.Z.H., K.O., C.O., O.M.), Kinki University School of Medicine, Osaka, Japan; and the Department of Food Science and Nutrition (S.U.), Kinki University School of Agriculture, Nara, Japan.
* To whom correspondence should be addressed. E-mail: hou_yz{at}yahoo.com.
Objective—Alpha2-antiplasmin (
2-AP) is the major circulating inhibitor of plasmin, which plays a determining role in the regulation of intravascular fibrinolysis. We investigated the role of
2-AP on vascular remodeling in response to angiotensin II (Ang II).
Methods and Results—
2-AP–deficient mice were performed. Ang II and N
-nitro- L-arginine methyl ester (L-NAME)–induced perivascular fibrosis was significantly decreased in
2-AP-/- mice compared with wild-type mice. In situ gelatinolytic activity analysis shows that perivascular gelatinolytic activity was increased in
2-AP-/- mice, which was responsible for decreased perivascular fibrosis in response to Ang II and L-NAME. Ang II–induced arterial wall thickening, vascular cell proliferation, apoptosis, c-Myc, and collagen I expression were significantly decreased in
2-AP-/- mice compared with wild-type mice. Further analysis shows that increased p53 and p21 expression were responsible for inhibition of Ang II–induced vascular remodeling in
2-AP-/- mice.
Conclusion—The results show that
2-AP is a critical regulator for vascular remodeling by inhibiting p53/p21 pathway, suggesting that
2-AP is proposed to be a potential therapeutic target for vascular remodeling.
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |